TNF and rheumatoid arthritis: While both studies conducted disease-specific analyses, our expanded dataset provides a clearer understanding of heightened TB risk in RA, as well as improved confidence intervals that narrow the uncertainty around TB risk levels associated with each TNF-α antagonist.